Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002034780 | SCV002107191 | uncertain significance | not provided | 2022-03-11 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Invitae | RCV002034779 | SCV002212751 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163997 | SCV003878183 | uncertain significance | Inborn genetic diseases | 2023-02-23 | criteria provided, single submitter | clinical testing | The c.3161G>A (p.R1054Q) alteration is located in exon 15 (coding exon 14) of the COL12A1 gene. This alteration results from a G to A substitution at nucleotide position 3161, causing the arginine (R) at amino acid position 1054 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |